The review outlines the molecular basis of HEV71 infection and highlights the potential for developing effective antiviral treatments and vaccines.
Answers are grounded in this paper and cite their sources.
Supports preclinical HEV71 vaccine development; leaves open human efficacy confirmation.
Over the past decade, Human enterovirus (HEV)71 has emerged as a highly significant cause of viral encephalitis in the south-east Asian region. A pattern of increased epidemic activity has been observable since 1997, the cause of which is unclear. Ongoing investigations into the molecular basis of HEV71 infection and virulence, in particular viral translation and replication, have confirmed similarities between HEV71 and other enteroviruses, including the prototype species Poliovirus, but more work is required in this field. Although several putative receptors for HEV71 have been identified, it remains likely that other, as yet unidentified, receptors exist. Work in several established animal models for HEV71 infection has confirmed the protective efficacy of several inactivated vaccines. As more information emerges regarding the molecular processes involved in HEV71 infection, further advances may lead to the development of more effective antiviral treatments and, ultimately, a vaccine protection strategy.
No takes yet. Share an insight, caveat, or question.
Bek et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: